12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
Clinical trial NCT00456794 · COMPLETED
Trial details
- NCT number
- NCT00456794
- Sponsor
- Kyowa Kirin, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2003-10-01
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.